During presentations at major medical conferences like the American Society of Nephrology’s Kidney Week, developers shared groundbreaking data showing that the trial met its co-primary endpoints with high statistical significance:
The trial began with a dramatic entrance by Agent Rina V007, who testified against Chikan as a key witness. Her evidence, corroborated by other witnesses and physical evidence seized during a coordinated raid on Chikan's hideout, left the defense with little room for argument. chikan undercover agent rina v007 trial met
ATEV Meets Primary Endpoints in Phase 3 Trial for ... - HCPLive During presentations at major medical conferences like the